We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Rexford Industrial Realty
REXR
$8.7B
| $496K | ﹤0.01% |
10,871
-2,999
| -22% | -$139K |
|
|
ORAN
1377
DELISTED
Orange
ORAN
| $496K | ﹤0.01% |
33,940
-20,086
| -37% | -$315K |
|
1378
Jefferies Financial Group
JEF
$12.9B
| $494K | ﹤0.01% |
24,152
+124
| +0.5% | +$2.35K |
|
1379
Resideo Technologies
REZI
$5.23B
| $494K | ﹤0.01% |
41,418
-8,638
| -17% | -$98.3K |
|
1380
Core Laboratories
CLB
$538M
| $493K | ﹤0.01% |
13,082
+4,403
| +51% | +$198K |
|
|
FINV
1381
FinVolution Group
FINV
$1.12B
| $493K | ﹤0.01% |
186,344
+62,659
| +51% | +$166K |
|
1382
Pultegroup
PHM
$24.5B
| $493K | ﹤0.01% |
12,717
-544
| -4% | -$21.1K |
|
1383
Supernus Pharmaceuticals
SUPN
$2.68B
| $493K | ﹤0.01% |
20,796
-5,802
| -22% | -$141K |
|
|
JBTM
1384
JBT Marel
JBTM
$7.14B
| $493K | ﹤0.01% |
4,371
+792
| +22% | +$84.8K |
|
1385
Iron Mountain
IRM
$38.2B
| $492K | ﹤0.01% |
15,468
-50
| -0.3% | -$1.64K |
|
1386
Matador Resources
MTDR
$6.31B
| $492K | ﹤0.01% |
27,361
-8,490
| -24% | -$127K |
|
1387
Invesco Large Cap Value ETF
PWV
$1.66B
| $489K | ﹤0.01% |
11,822
-74
| -0.6% | -$2.95K |
|
1388
Valmont Industries
VMI
$9.44B
| $488K | ﹤0.01% |
3,258
+46
| +1% | +$6.5K |
|
1389
Cboe Global Markets
CBOE
$29.8B
| $486K | ﹤0.01% |
4,052
+2,732
| +207% | +$320K |
|
1390
Fortis
FTS
$30B
| $486K | ﹤0.01% |
11,686
-1,203
| -9% | -$49.2K |
|
1391
Encompass Health
EHC
$11.2B
| $484K | ﹤0.01% |
8,788
-815
| -8% | -$44.2K |
|
1392
Titan International
TWI
$516M
| $484K | ﹤0.01% |
133,617
| – | – |
|
1393
AAR Corp
AIR
$5.15B
| $482K | ﹤0.01% |
10,669
-1,394
| -12% | -$60.5K |
|
1394
Fabrinet
FN
$17.1B
| $482K | ﹤0.01% |
7,443
-2,372
| -24% | -$137K |
|
|
GRMN
1395
Garmin
GRMN
$46.9B
| $482K | ﹤0.01% |
4,951
+611
| +14% | +$57K |
|
1396
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.05B
| $482K | ﹤0.01% |
9,524
+493
| +5% | +$25K |
|
1397
Brink's
BCO
$5.02B
| $481K | ﹤0.01% |
5,308
-392
| -7% | -$34.6K |
|
1398
OneSpan
OSPN
$562M
| $481K | ﹤0.01% |
28,110
-3,333
| -11% | -$56.7K |
|
|
P
1399
Everpure Inc
P
$24.8B
| $481K | ﹤0.01% |
28,109
| – | – |
|
1400
iShares Global Tech ETF
IXN
$8.7B
| $478K | ﹤0.01% |
13,626
+402
| +3% | +$13.2K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.